Do GLP-1RA and SGLT2i Reduce Cardiovascular Mortality in African American Patients with Type 2 Diabetes? A Meta-analysis

被引:0
|
作者
Mishriky, Basem M.
Powell, James R.
Wittwer, Jennifer A.
Chu, Jennifer X.
Sewell, Kerry
Wu, Qiang
Cummings, Doyle M.
机构
关键词
D O I
10.2337/db19-242-OR
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
242-OR
引用
收藏
页数:2
相关论文
共 50 条
  • [1] GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
    Pablo, Aschner
    Evelyn, Blanc
    Claudia, Folino
    Yanina, Morosan A.
    CURRENT HYPERTENSION REVIEWS, 2021, 17 (02) : 149 - 158
  • [2] Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
    Khat, Dorrin Zarrin
    Husain, Mansoor
    CURRENT DIABETES REPORTS, 2018, 18 (07)
  • [3] Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
    Dorrin Zarrin Khat
    Mansoor Husain
    Current Diabetes Reports, 2018, 18
  • [4] Anticipating the Impact of 2019 Guidelines: Use of SGLT2i and GLP-1RA in Patients with Diabetes and Cardiovascular Disease
    Rattelman, Cori R.
    Ciemins, Elizabeth L.
    Cuddeback, John K.
    DIABETES, 2019, 68
  • [5] Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes
    Mishriky, Basem M.
    Cummings, Doyle M.
    Powell, James R.
    PRIMARY CARE DIABETES, 2022, 16 (03) : 471 - 473
  • [6] Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: Rationale and design of a randomized controlled trial
    Haff, Nancy
    Horn, Daniel M.
    Bhatkhande, Gauri
    Sung, Meekang
    Colling, Caitlin
    Wood, Wendy
    Robertson, Ted
    Gaposchkin, Daniel
    Simmons, Leigh
    Yang, Judy
    Yeh, James
    Crum, Katherine L.
    Hanken, Kaitlin E.
    Lauffenburger, Julie C.
    Choudhry, Niteesh K.
    AMERICAN HEART JOURNAL, 2025, 285 : 39 - 51
  • [7] The Difference in the Effects on Microalbuminuria Depending on the Order of GLP-1RA and SGLT2i Therapy in Type 2 Diabetes
    Ohara, Masaya
    Motoyama, Koka
    Tamai, Anna
    Sakura, Takeshi
    Yakushiji, Yosuke
    Hosoi, Masayuki
    DIABETES, 2019, 68
  • [8] Glycaemic control and beta cell function in type 2 diabetes on SGLT2i and GLP-1RA combination therapy
    Martinez, R.
    Al-Jobory, H.
    Adams, J.
    Chavez-Velasquez, A.
    Triplitt, C.
    DeFronzo, R. A.
    Cersosimo, E.
    DIABETOLOGIA, 2017, 60 : S408 - S409
  • [9] The comparative effects of metabolic surgery, SGLT2i, or GLP-1RA in patients with obesity and type 2 diabetes: a retrospective cohort study
    Wu, Tingting
    Wong, Carlos K. H.
    Tang, Eric H. M.
    Man, Kenneth K. C.
    Wong, Simon K. H.
    Au, Ivan Chi Ho
    Tse, Emily T. Y.
    Chan, Esther W. Y.
    Grieve, Eleanor
    Wu, Olivia
    Ng, Enders K. W.
    Wong, Ian C. K.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2022, 18 (06) : 762 - 771
  • [10] Cardiovascular outcome with SGLT2i and GLP1RA
    Lim, Soo
    Sohn, Minji
    Nauck, Michael A.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 129 : 133 - 136